Showing results (321-330 of 352) with videos related to
Sort By:
Pageof 36
Blood Advances|November 2, 2022
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AMLGhayas C Issa, Aram Bidikian, Sangeetha Venugopal, et al.Digestive Diseases and Sciences|May 1, 2012
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infectionPaul J Clark, Alexander J Thompson, Qianqian Zhu, et al.Journal of the American Heart Association|February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term OutcomesAyman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.Journal of Wound Care|April 20, 2023
Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs)Stephanie Wu, Marissa Carter, Windy Cole, et al.The American Journal of Gastroenterology|January 4, 2023
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis BNorah A Terrault, Anna S Lok, Abdus S Wahed, et al.Oncotarget|March 9, 2018
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsGuillermo Montalban-Bravo, Koichi Takahashi, Keyur Patel, et al.Clinical Spine Surgery|May 8, 2026
Comparison Between Short-Term and 1-Year Patient-Reported Outcome Measures After Anterior Cervical Discectomy and FusionJonathan Dalton, Robert J Oris, Omar Tarawneh, et al.The New England Journal of Medicine|April 24, 2013
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment optionsIra M Jacobson, Stuart C Gordon, Kris V Kowdley, et al.Blood|December 23, 2016
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumabYasmin Abaza, Hagop Kantarjian, Guillermo Garcia-Manero, et al.Pageof 36